Package 70594-069-02

Brand: neostigmine methylsulfate

Generic: neostigmine methylsulfate
NDC Package

Package Facts

Identity

Package NDC 70594-069-02
Digits Only 7059406902
Product NDC 70594-069
Product ID 70594-069_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90
Description

10 VIAL in 1 CARTON (70594-069-02) / 10 mL in 1 VIAL (70594-069-01)

Marketing

Marketing Status
Marketed Since 2021-01-11
Brand neostigmine methylsulfate
Generic neostigmine methylsulfate
Sample Package No

Linked Drug Pages (1)

Neostigmine Methylsulfate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "74ccc6d9-bde5-4c06-b40f-7980c5d5ca90", "openfda": {"unii": ["98IMH7M386"], "rxcui": ["311935", "311936"], "spl_set_id": ["398d8193-e1e8-42b5-a95a-86cde967c7d0"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (70594-069-02)  / 10 mL in 1 VIAL (70594-069-01)", "package_ndc": "70594-069-02", "marketing_start_date": "20210111"}], "brand_name": "Neostigmine Methylsulfate", "product_id": "70594-069_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "70594-069", "generic_name": "Neostigmine Methylsulfate", "labeler_name": "Xellia Pharmaceuticals USA LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine Methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": ".5 mg/mL"}], "application_number": "ANDA213074", "marketing_category": "ANDA", "marketing_start_date": "20210110", "listing_expiration_date": "20261231"}